RJT
ZYME icon

Raymond James Trust’s Zymeworks ZYME Stock Holding History

Raymond James Trust’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,233
Closed -$200K – 1235
2021
Q4 		$200K Buy
12,233
+550
+5% +$11.5K 0.01% 1124
2021
Q3 		$339K Buy
11,683
+1,550
+15% +$51.5K 0.01% 796
2021
Q2 		$352K Buy
10,133
+26
+0.3% +$825 0.01% 784
2021
Q1 		$319K Buy
10,107
+1,800
+22% +$73.2K 0.01% 800
2020
Q4 		$393K Hold
8,307
– – 0.02% 643
2020
Q3 		$387K Buy
+8,307
New +$285K 0.02% 576

Other funds holding ZYME

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Raymond James Trust's ZYME Position: Q1 2022 in Review

Raymond James Trust sold out of Zymeworks (ZYME) in Q1 2022, closing a stake of 12,233 shares — an estimated $200K sold.

Raymond James Trust first reported a position in ZYME in Q3 2020 and held it in 6 quarters. The position peaked at $393K in Q4 2020. 120 funds tracked by Wall St. Rank hold ZYME as of Q1 2022.

  • Raymond James Trust reported no remaining Zymeworks position as of Q1 2022 after selling out during the quarter.
  • Raymond James Trust sold 12,233 Zymeworks shares in Q1 2022, an estimated $200K.
  • Raymond James Trust first reported a position in Zymeworks in Q3 2020 and held it in 6 quarters.
  • Raymond James Trust's Zymeworks position peaked at $393K in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Zymeworks as of Q1 2022.

Based on Raymond James Trust's 13F filing for Q1 2022, filed 12 May 2022.